Myeloproliferative Neoplastic Diseases Observatory From Brest

Recruiting now

Conditions studied: Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis

In brief

All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).

Key facts

Study ID

NCT02897297

Run by

University Hospital, Brest

People needed

1000

Starts

2015-09-01

Expected to finish

2025-09-30

Last updated by the study team

2024-08-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis
• Signature of the non-opposition consent form

You may not qualify if…

• None

Where it is running

• CHRU de Brest — Brest, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.